Primary investigators and projects

Anne-Marie Aas

1) The Fiberdia project - Effects of prebiotic fibres on gut microbiota and hormones regulating blood glucose and appetite in type 2 diabetes

Kåre I. Birkeland

1) A retrospective nationwide cohort study to investigate the treatment of diabetes in adults in Norway - DAPHNE

2) The DISCOVER-study - Diabetes and cardiovascular risk factor in general practice in the Nordic countries and world-wide

3) The MyoGlu-study - A controlled, intervention study of high-intensive exercise training in subjects with abnormal glucose tolerance and controls

4) The DIASA Research Programme

Tore Julsrud Berg

1) The DIALONG-study - The status of long-term survivors of type 1 diabetes

Esben Selmer Buhl

1) Outcomes & Multi-morbidity In Type 2 diabetes (OMIT) – a national registry-based observational cohort with focus on care and treatment of key high-risk groups in Norway

Knut Dahl-Jørgensen

1) Diabetes Virus Detection Study (DiViD)

2) DiViDInt: Diabetes Virus detection and Intervention Trial

3) INNODIA

4) Long term vascular changes in type 1 diabetes - Clinical aspects and biological markers - 30 years follow-up of the Oslo Study

Åse Ruth Eggemoen

1) The STORK-Groruddalen cohort study: Vitamin D and ethnic differences

Hanne Løvdal Gulseth

1) The 4B study - Effects of bariatric surgery on bone, bone marrow fat and glucose metabolism in subjects with and without type 2 diabetes and morbid obesity

2) The POSDIT study - Population-based studies of social inequalities of diabetes diagnosis, incidence, mortality and treatment

Sara Salehi Hammerstad

1) Virus and Pathogenic Mechanisms in Autoimmune Diseases Towards Cure and prevention

Martin Heier

1) HDL function in diabetes

2) Prevention of atherosclerosis

Trond Geir Jenssen

1) Magnesium and hyperglycemia after kidney transplantation: A new target for treatment

2) Magnesium and Calcification index (T50) in renal transplant recipients

3) What is the experience of a multidisciplinary out-clinic aimed to select of patients for beta-cell replacement transplantation?

4) What is the long-term outcome of single pancreas vs. combined pancreas-kidney transplantation?

Anne Karen Jenum

1) ROSA-4

2) The STORK-Groruddalen cohort study (STORK G-1 and STORK G-2)

Geir Joner

1) Cardiovascular and end-stage renal disease in type 1 diabetes with onset before 15 years of age and long duration.

Svein Olav Kolset

1) Extracellular matrix and diabetic nephropathy

Lars Krogvold

1) DiViDInt: Diabetes Virus detection and Intervention Trial

Tove Lekva

1) Pregnancy as a "stress test for life”- A Longitudinal Extension of the STORK Cohort

Benedicte A. Lie

1) Functional studies of thymus and T cells with relation to autoimmunity

Hanna Dis Margeirsdottir

1) Atherosclerosis in Childhood Diabetes - a population-based, prospective study

Gunn-Helen Moen

1) Why does low birthweight increase the risk of type 2 diabetes and other cardiometabolic diseases?

Anne Pernille Ofstad

1) The HUNT for HF Risk Score

Elisabeth Qvigstad

1) Fertility in diabetes and prediabetes in Norway

Marie Cecilie Passche Roland

1) The STORK project - Maternal metabolic syndrome, macrosomic offspring and pregnancy complications

Hanne Scholz

1) ABINO: Artificial Biomimetic systems – the Niche of Islet Organoids

2) Development of beta cell replacement therapy for type 1 diabetes

Torild Skrivarhaug

1) ADHD in children and adolescents with Type 1 diabetes; Do they have an increased risk of diabetic complications?

2) Early nutrition and risk of islet autoimmunity and type 1 diabetes

3) How do young people with Type 1 diabetes (T1D) experience transition from pediatric to adult health care?

4) Joint International Project. Diabetes ketoacidosis (DKA) at onset of pediatric type 1 diabetes

5) Does normal blood glucose (Time-in-Range) preserve insulin production in children with newly diagnosed Type 1 diabetes?

6) The DISABKIDS© generic and diabetes specific modules are valid but not directly comparable between Denmark, Sweden and Norway

7) The Norwegian Childhood Diabetes Registry (NCDR) and Biobank

8) The Use of Insulin Pumps (CSII) and Continuous Glucose Monitoring (CGM): Does it Make a Difference?

Line Sletner

1) Are epigenetic modifications of key genes in placenta important links between mother’s lifestyle and fetal pre- and postnatal growth patterns and future diabetes risk?

2) Prediction of gestational diabetes from four Norwegian studies (PreGeDiab4N)

Christine Sommer

1) SA diet – improving dietary assessment in individuals of South Asian origin living in Norway

2) Soluble leptin receptor - Clinical and mechanistic studies to explore the relationship with insulin resistance and glucose metabolism

3) The EPIPREG project - Genetics and epigenetics in a population-based, prospective cohort of pregnant women

Lars Christian Stene

1) HEDIMED: Human Exposomic Determinants of Immune Mediated Diseases

2) MIDIA project - Environmental causes of type 1 diabetes

3) The PAGE study - Prediction of Autoimmune diabetes and celiac disease in childhood by Genes and perinatal Environment

Kari Anne Sveen

1) Long term vascular changes in type 1 diabetes - Clinical aspects and biological markers - 30 years follow-up of the Oslo Study

Per Medbøe Thorsby

1) Gene expression of glucose and vitamin D stimulated rodent and human islets

2) Metabolomic profiling of hyperglycemic clamp in humans

3) Tmem27-marker for ß-cell mass

Marte K. Viken

1) The role of immune cell receptors in disease


Christin W. Waage

1) Women and the risk of type 2 diabetes

Line Wisting

1) Type 1 Diabetes and Disturbed Eating Behavior